ArticleBreast cancer (Dove Medical Press)2026

Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer.

Yujing Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.